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Abstract
Background Solitary ﬁbrous tumor of the pleura (SFTP)
represents a clinical entity rarely encountered, especially in
giant forms. Complete surgical resection for giant tumor of
pleura is a challenge. The aim of this article is to present
ﬁve new cases of giant SFTP, and to discuss their clini-
cal characteristics and the treatment strategy of such
neoplasms.
Methods We performed a retrospective review of the
clinical records of ﬁve patients who underwent surgery for
a huge SFTP ([18 cm in diameter) between 2007 and
2009.
Results Four patients were symptomatic. All ﬁve patients
underwent angiography and embolization of the tumor-
supplying vessels within 24 h of surgery. All giant tumors
were removed completely by extended postlateral thora-
cotomy with moderate intraoperative bleeding. Two wedge
resections and one lobectomy were performed in three
cases where the parenchyma had been encroached. Tumors
in three patients were pathologically benign; those in the
other two were malignant. The symptoms disappeared in
all cases after surgery.
Conclusions Complete resection remains the mainstay of
cure for giant SFTP. We recommend preoperative angi-
ography and embolization for giant SFTP which can reduce
the risk of hemorrhage and can contribute to piecemeal
removal for radical excision.
Introduction
Solitary ﬁbrous tumor of the pleura (SFTP) represents a
rare, slow-growing neoplasm. Historically, several differ-
ent names have been used to designate this neoplasm
because of controversy surrounding its histogenesis.
Nowadays, the origin is recognized widely as mesenchy-
mal cells of submesothelial tissues of the pleura rather than
mesothelial cells [1]. Solitary ﬁbrous tumors of the pleura
are usually asymptomatic in their early stage and are often
discovered incidentally by routine chest X-ray. Parts of
these tumors tend to grow into massive lesions before there
is evidence of local compression symptom. Surgery is the
mainstay of therapy for SFTP. Complete excision of giant
SFTP is a challenging task because of poor exposure, a
signiﬁcant tumor blood supply, and heavy adhesions,
among other characteristics. In this article we report our
experience with ﬁve patients with giant SFTP who under-
went operation.
Materials and methods
From March 2007 to December 2009, of 29 patients with
SFTP treated surgically in the Department of Thoracic
Surgery of the Chinese People’s Liberation Army General
Hospital, 5 (17.2%) had giant tumors[18 cm in diameter,
including four men and one woman, 57 years old on an
average (age range: 44–78 years). One case was discovered
by chance whereas four had symptoms related to the tumor,
as follows: three with exertional dyspnea, one with right
upper limb pain and fever. Expect for distal clubbing in one
patient, there were no other paraneoplastic syndromes.
None had a history of asbestos exposure. All patients
underwent careful preoperative routine tests including
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monary function test. Two patients underwent magnetic
resonance imaging (MRI) scan and one underwent gas-
troscopic examination. A CT-guided percutaneous biopsy
was performed preoperatively in all cases. Hematoxylin
and eosin (H&E) staining and immunostaining, including
vimentin, CD34, and CD31, were performed in each biopsy
sample.
All patients underwent angiography and embolization of
the tumor-supplying vessels on the day before operation
(\20 h). Patients were maintained at a 45 lateral decubitus
position during operation. Clinical data and other preop-
erative and postoperative characteristics are presented in
Table 1.
Outpatient follow-up was performed at 1, 3, and
6 months with a standard chest X-ray, then once a year
with a chest CT scanning.
Results
Computedtomographyscanningofallﬁvepatientsshoweda
huge lobulated heterogeneous mass with focal low attenua-
tion, with apparent compression of the mediastinum and the
lung (Figs. 1, 2). Three of these tumors were located in the
right hemithorax and two in the left. Magnetic resonance
imaging revealed a cystic change zone and vascular ﬂow
voids (Fig. 3). Varicosity was observed in the inferior seg-
ment of the esophagus by gastroscopic examination in the
patient with the largest tumor. Angiography delineated
multiple feeding vessels of tumor, including several inter-
costals, as well as the internal mammary, inferior phrenic,
andbronchialarteries(Fig. 4).TheCT-guidedpercutaneous
biopsydemonstratedaspindlecelltumorinthreepatientsand
failed to provide a conclusive result in other two. The diag-
nosis of SFTP was established before operation by immu-
nohistochemical stains, which showed positivity for
vimentin and CD-34, but negative stain for CD-31.
All patients underwent complete surgical resection of
the tumor via an extended postlateral thoracotomy. Tumors
were completely removed by piecemeal resection in four
cases because of huge bulk, poor exposure, and extensive
vascular adhesions. In three cases, en-bloc excision of
tumor plus the involved lung was performed, two by wedge
resection and one by anatomic lobectomy. The tumor
appeared to arise from the parietal pleura in two cases, the
visceral pleura in two, and the mediastinal pleura in one.
The volume of bleeding during operation was 800 ml on
average. The tumors ranged from 18 to 32 cm in diameter
(mean: 25 cm) and weighed between 2,000 and 4,300 g
(mean: 3,300 g) (Fig. 5). The preoperative symptoms dis-
appeared after surgery in all patients. Entrapped lung
achieved complete re-expansion proved by chest X-ray in
four patients after operation. Re-dilatation pulmonary
edema occurred on the second postoperative day in one
case, and was relieved by administration of glucocorticoid.
There were no other postoperative complications (mean
hospital stay: 12.6 days).
The macroscopic evaluation showed solid masses that
were well encapsulated in appearance. The cut surface was
Table 1 Clinical characteristics of resected tumors of ﬁve patients with a giant solitary ﬁbrous tumor of the pleura
No. Age (years) Gender Side Histology Size (cm) Weight (g) Survival
1 44 Male Left Benign 32 9 22 9 19 4,300 Alive
2 54 Male Right Benign 25 9 25 9 16 3,200 Alive
3 61 Female Right Benign 18 9 14 9 12 3,000 Alive
4 48 Male Left Malignant 20 9 10 9 9 2,000 Alive
5 78 Male Right Malignant 30 9 25 9 20 4,000 Alive
Fig. 1 Contrast-enhanced
computed tomography (CT)
scan demonstrates a
heterogeneously enhancing soft-
tissue giant mass on the left
(a) and right (b) hemithorax
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soft and brittle in the other two. All tumors had signiﬁcant
blood supply. Two tumors were malignant and the other
three were benign according to the pathologic criteria of
England et al. [1]. Vimentin and CD34 of immunohisto-
chemistry evaluation were positive in all cases.
A short-term clinical and radiological follow-up
(a median follow-up of 27.8 months) showed all ﬁve
patients were free of disease.
Discussion
Giant solitary ﬁbrous tumor of the pleura is a rare form of
pleural disease that is only occasionally cited in the liter-
ature, usually as single cases [2, 3]. The peak incidence of
SFTP occurs in the ﬁfth to eighth decades but may be
found in any age group [4–6]. Most SFTPs are benign and
develop slowly [1]. These tumors often have an asymp-
tomatic clinical course. Thus tumors tend to grow into huge
mass before local compression symptoms develop, espe-
cially in patients without routine physical examinations.
About 50% of patients reported in the literature are
symptomatic [4, 5]. Larger tumors may have a higher
percentage of symptomatology.
In most cases, thoracic CT scan demonstrates a well-
circumscribed, lobular, homogenous, soft-tissue mass [7].
However, large tumors are frequently heterogeneous due to
necrosis, hemorrhage, or cystic changes. In our series, CT
scan in all ﬁve cases showed heterogeneous density.
Atelectasis, displacement of adjacent structures, and pleu-
ral effusion presented more frequently in giant SFTP. An
MRI allows visualization of the diaphragm and is a sen-
sitive instrument to exclude invasion of neighboring
structures. An MRI is also helpful for assessing the vas-
cular bed, although angiograms are more deﬁnitive [8].
A CT-guided aspiration biopsy was not considered a reli-
able tool because of its low diagnostic accuracy as reported
by several authors [4–6, 9]. Nevertheless we obtained a
satisfactory conclusive diagnosis by biopsy in three cases
among ﬁve. Appropriate biopsy site, adequate specimens,
and reference to immunohistochemical analysis may be of
beneﬁt for preoperative pathologic diagnosis.
Fig. 2 Contrast-enhanced CT scan shows a massive tumor occupying
most of the left hemithorax, producing mass effect on the medias-
tinum, diaphragm, and abdominal organs
Fig. 3 Magnetic resonance imaging (MRI) demonstrates the ﬁbrous
characteristic of the giant mass in the right hemithorax
Fig. 4 a Angiography shows
abundant feeding vessels of
SFTP from the intercostal
arteries. b Supplying vessels
were embolized by polyvinyl
alcohol through a microcatheter
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123It is well known that maximal treatment of SFTP is
based on surgical excision. Resection is generally curative
in all benign cases, and in approximately half of malignant
cases [1]. Complete resection for giant tumor of the pleura
is a challenging task because of poor exposure, signiﬁcant
blood supply, and other factors. Angiography is an
important investigative tool with which to delineate major
feeding vessels of tumor, which can be embolized before
operation [7, 10, 11]. Preoperative embolism of major
vessels can make operation safer by signiﬁcantly reducing
the risk of bleeding. In the series reported by England et al.,
ﬁve patients had aberrant vessels including a branch of the
phrenic artery and a bronchial artery [1]. Angiography in
those ﬁve cases demonstrated that the major blood supply
to the tumor was from the intercostals, the internal mam-
mary, inferior phrenic, and bronchial arteries. Polyvinyl
alcohol (PVA) granules, microcoils, and sponge granules
are used to embolize the blood supply through a micro-
catheter. Surgery should then be carried out within 24 h for
minimal blood loss. Too long a delay may reduce the
effectiveness of embolization.
A giant sessile tumor with good movement may com-
press the heart and draw down blood pressure when the
thoracic cavity is open. The 45 lateral decubitus position
during operation is an easy and reasonable way to avoid
compression. Peri-tumor extensive adhesions make it more
difﬁcult to ligate feeding vessels and handle hilar vessels,
especially in a tumor with a broad-based pedicle. Piece-
meal resection proved to be a practical method for removal
of giant SFTP, because it can achieve better exposure and
avoid impairing adjacent structure. Extended excision is
necessary in cases of ‘‘inverted ﬁbroma,’’ invasive tumor
[3, 12]. Wedge resection is enough in most cases [4].
The completeness of surgical excision was an important
prognostic factor for both benignity and malignancy. Thus
some authors advocated intraoperative pathology exami-
nation in every case to obtain microscopically free surgical
margins [13, 14]. To reduce operative time, we used
extensive electric coagulation to pedicle rather than intra-
operative frozen section to avoid recurrence in the two
tumors that originated from the parietal pleura. We think
that an intraoperative pathological examination is neces-
sary in parietal pleura broad-based tumor in order to assess
the surgical margins.
Atelectasis occurs frequently in giant SFTP, and
removal of a giant tumor might result in pulmonary edema.
It is therefore beneﬁcial to use mechanism ventilation with
positive end-expiratory pressure (PEEP) during the ﬁrst
postoperative day. And it is important for these patients
to undergo chest X-rays to check postoperative lung
re-expansion.
The great majority of patients undergoing surgical
removal of an SFTP have a benign clinical course, with a
long-term disease-free survival in around 90% of the cases
[4, 5, 14]. Long-term follow-up after complete resection is
necessary because of the possibility of late recurrence of
SFTP, especially in malignant ones [4].The follow-up of
the two patients with malignant tumors in our series is too
short (4 and 32 months, respectively) to establish a clinical
judgment.
In conclusion, CT-guided aspiration biopsy, including
immunopathologic examination, is helpful for preoperative
diagnosis in SFTP. Angiography and embolization are
important and useful in the diagnosis and treatment of giant
SFTP. We advise that angiography and embolization
should be done before operation in all giant tumors of the
chest, including SFTP.
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